Startup Advances Dosing Study of Oral Therapy for Type 1 Diabetes
A novel oral therapy that targets beta cell health and islet cell function has begun a phase 1 single ascending...
Startup
A novel oral therapy that targets beta cell health and islet cell function has begun a phase 1 single ascending...
